港股異動 | 吉利(0175.HK)漲超9%創逾17年新高 績後獲多家機構看好
格隆匯1月8日丨吉利汽車(0175.HK)高開高走,盤中高見30.6港元創1993年12月13日以來逾17年新高,現漲9.35%報30.4港元,暫成交8億港元,最新總市值2984億港元。吉利前日(6日)盤後宣佈,集團2020年總銷量超132萬部,2021年銷量目標定為153萬部,同比增約16%。績後花旗發報吿指,維持吉利為該行中資汽車股首選,料其業務迎來轉向及可獲市場重估,維持其買入評級及目標價41港元。大和亦指吉利去年12月份的總銷量有強勁增長,重申買入評級,料集團今年將實現強勁盈利增長。此外,美銀證券、瑞信、摩根大通均看好吉利,分別給予32.1、33及50港元的目標價。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.